TheEdgeResearch
Home / Stocks / FDMDF

4DMedical Limited (FDMDF)

OTC Healthcare Medical - Devices
$1.50 ▲ +0.00%
Market Cap
$903.5M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.97
52-Wk Range
0.8701-5
CEO
Andreas Fouras
Country
AU
Currency
USD

4DMedical Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carlton, VIC, AU. The stock last traded at $1.50, up 0.00% on the session, giving a market capitalisation of $903.5M. On trailing twelve-month figures it carries a trailing P/E of -5.48, a net margin of -2895.1%. Its beta of 1.97 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-5.48
Price / Sales
184.25
Price / Book
7.58
EV / EBITDA
-19.74
Gross margin
-539.2%
Operating margin
-813.7%
Net margin
-2895.1%
Return on equity
—
Debt / equity
0.02
Current ratio
30.79
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
181
IPO date
2021-02-02
Headquarters
Carlton, VIC, AU
About 4DMedical Limited

Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Technology, an advanced system for four-dimensional lung imaging. Beyond this core offering, its suite of products includes a software-as-a-service (SaaS) delivery model, specialized XV lung ventilation analysis software, and Permetium—a preclinical imaging system designed to quantify regional changes in pulmonary function. Additionally, the firm provides the AccuVent 200, a ventilator tailored for small animals.

More research on FDMDF
FDMDF technical analysis FDMDF TheEdge Score Compare against peers
Open full interactive analysis & DCF →